Literature DB >> 15067856

Establishment of a database of diagnosed HCV-infected persons in Scotland.

L Shaw1, A Taylor, K M Roy, S O Cameron, S Burns, P Molyneaux, P McIntyre, G Codere, D Goldberg.   

Abstract

To provide a comprehensive understanding of the epidemiology of hepatitis C virus (HCV) infection in Scotland, a database of all persons known to have been infected with HCV in Scotland was established. Non-identifying data, held on the computers and requests forms in Scotland's principal and confirmatory HCV testing laboratories, were entered onto a National Database at the Scottish Centre for Infection and Environmental Health. As at December 2001, records from 13,519 persons in Scotland known to have been infected with HCV had been entered on to the database (one in 378 of Scotland's population). Of the 13,519, 69% were male and 90% of the 9,092 for whom risk factor information was available had injected drugs; 37% were from Greater Glasgow. Fifty-six per cent of the 13,519 were diagnosed between 1998 and 2001; 1,727 (23%) of the new diagnoses from 1998 to 2001 were aged under 25 years. The data provide an insight into the epidemiology of HCV infection in Scotland. They support other data, which indicate that the current major risk factor for HCV in the country is injecting drug use.

Entities:  

Mesh:

Year:  2003        PMID: 15067856

Source DB:  PubMed          Journal:  Commun Dis Public Health        ISSN: 1462-1843


  6 in total

1.  Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.

Authors:  K M Roy; S J Hutchinson; S Wadd; A Taylor; S O Cameron; S Burns; P Molyneaux; P G McIntyre; D J Goldberg
Journal:  Epidemiol Infect       Date:  2006-08-08       Impact factor: 2.451

2.  Mortality of those who attended drug services in Scotland 1996-2006: record-linkage study.

Authors:  Elizabeth L C Merrall; Sheila M Bird; Sharon J Hutchinson
Journal:  Int J Drug Policy       Date:  2011-06-30

3.  Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland.

Authors:  Teresa C Prevost; Anne M Presanis; Avril Taylor; David J Goldberg; Sharon J Hutchinson; Daniela De Angelis
Journal:  Addiction       Date:  2015-06-08       Impact factor: 6.526

4.  Liver function tests in primary care provide a key opportunity to diagnose and engage patients with hepatitis C.

Authors:  A McLeod; S J Hutchinson; A Weir; S Barclay; J Schofield; C Gillespie Frew; D J Goldberg; M Heydtmann; E Wilson-Davies
Journal:  Epidemiol Infect       Date:  2022-06-27       Impact factor: 4.434

Review 5.  Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence.

Authors:  Matthew Hickman; Daniela De Angelis; Peter Vickerman; Sharon Hutchinson; Natasha Kaleta Martin
Journal:  Curr Opin Infect Dis       Date:  2015-12       Impact factor: 4.915

6.  A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland.

Authors:  S A McDonald; S J Hutchinson; S M Bird; C Robertson; P R Mills; J F Dillon; D J Goldberg
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.